Lipodystrophy: all 165 studies
Page 1 of 2. Open to participants first (11), then studies with results posted, then the rest; newest registration first within each.
- Sexual Quality of Life in Female Patients With Lipodystrophy Syndromes or Turner's Syndrome: a Case-control StudyNot yet recruitingNCT07799012
- Effects of Meal Macronutrients on Postprandial LipidsNot yet recruitingNCT07313787Phase 2
- The Skin Barrier in Users of Diabetes DevicesRecruitingNCT06856954
- Susceptibility to Infectious Diseases in obEsity: an endocRine trAnslational socioLogic Evaluation, "SIDERALE"RecruitingNCT06236932Not applicable
- Feasibility of Adipose Tissue Triglyceride (TG) Labelling in Familial Partial Lipodystrophy (FPLD)RecruitingNCT05996536
- Natural History of Pregnancy and Pregnancy Outcomes in Metreleptin-Treated vs Untreated Subjects With LipodystrophyRecruitingNCT05419037
- Expanded Access to REGN4461 for Patients With Diseases Associated With Deficient Leptin SignalingAvailableNCT04710056
- Low Energy Diet and Familial Partial LipodystrophyRecruitingNCT03900286Not applicable
- Registry for Patients With LipodystrophyRecruitingNCT03553420
- The LD Lync Study - Natural History Study of Lipodystrophy SyndromesRecruitingNCT03087253
- MEASuRE: Metreleptin Effectiveness And Safety RegistryRecruitingNCT02325674
- Immunogenicity of Metreleptin in Patients With Generalized LipodystrophyCompletedNCT04026178Phase 4Results posted
- The PREFORM Study: Rotational Fractional Resection for Submental ContouringCompletedNCT03966924Not applicableResults posted
- Study of AKCEA-ANGPTL3-LRx (ISIS 703802) in Participants With Familial Partial Lipodystrophy (FPL)CompletedNCT03514420Phase 2Results posted
- Study of Gemcabene in Adults With FPLDCompletedNCT03508687Phase 1/2Results posted
- CONFORM: Rotational Fractional Resection for Submental ContouringCompletedNCT03407313Not applicableResults posted
- Aramchol for HIV-associated Nonalcoholic Fatty Liver Disease and LipodystrophyCompletedNCT02684591Phase 2Results posted
- CLINICAL PROTOCOL to Investigate the Long-term Safety and Efficacy of Metreleptin in Various Forms of Partial LipodystrophyCompletedNCT02654977Phase 2Results posted
- Efficacy, Safety and Tolerability of ISIS 304801 in People With Partial Lipodystrophy With an Open-Label ExtensionCompletedNCT02639286Phase 2Results posted
- The BROADEN Study: A Study of Volanesorsen (Formerly IONIS-APOCIIIRx) in Participants With Familial Partial LipodystrophyTerminatedNCT02527343Phase 2/3Results posted
- Clinical Evaluation of Venus Versa Octipolar Applicator for Reduction of Abdomen CircumferenceTerminatedNCT02492997Not applicableResults posted
- Phase 2 Study of Obeticholic Acid for Lipodystrophy PatientsCompletedNCT02430077Phase 2Results posted
- Voluma Filler Agent For The Treatment of HIV-associated Facial LipoatrophyCompletedNCT02342223Phase 1Results posted
- Short-term Effects of Leptin in People With LipodystrophyCompletedNCT01778556Phase 2Results posted
- Clinical Protocol to Investigate the Efficacy of Recombinant Human Leptin (Metreleptin) in Nonalcoholic Steatohepatitis (NASH) or Nonalcoholic Fatty Liver Disease (NAFLD) Associated With LipodystrophyCompletedNCT01679197Phase 2Results posted
- Study of the Cabochon System for Improvement in the Appearance of CelluliteCompletedNCT01671839Not applicableResults posted
- Metabolic Abnormalities in HIV-infected PersonsCompletedNCT01612858Phase 4Results posted
- Leptin for Abnormal Lipid Kinetics in HIV Lipodystrophy SyndromeCompletedNCT01511016Not applicableResults posted
- Effects of Growth Hormone Releasing Hormone in HIVCompletedNCT01263717Not applicableResults posted
- HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone)CompletedNCT01023620Not applicableResults posted
- Morphological and Functional Evaluation of Buttock Lipoatrophy Treatment With MacrolaneCompletedNCT00931268Not applicableResults posted
- Trial of Leptin Replacement Therapy in Patients With LipodystrophyCompletedNCT00896298Phase 2/3Results posted
- Effects of Short-term Growth Hormone in HIV-infected PatientsCompletedNCT00795210Not applicableResults posted
- Myocardial Function & FFA Metabolism in HIV Metabolic SyndromeCompletedNCT00656851Not applicableResults posted
- Raltegravir Therapy for Women With HIV and Fat AccumulationCompletedNCT00656175Phase 2Results posted
- Exercise and Pioglitazone for HIV-Metabolic SyndromesCompletedNCT00639457Not applicableResults posted
- TH9507 Extension Study in Patients With HIV-Associated LipodystrophyCompletedNCT00608023Phase 3Results posted
- Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin TighteningCompletedNCT00585715Not applicableResults posted
- Therapeutic Approaches to HAART-Induced LipodystrophyCompletedNCT00461552Phase 2Results posted
- Mechanisms of Lipodystrophy in HIV-Infected PateintsCompletedNCT00457665Phase 4Results posted
- Cholic Acid for Hepatic Steatosis in LipodystrophyCompletedNCT00457639Phase 2Results posted
- Rosiglitazone Effect on Mitochondria and LipoatrophyCompletedNCT00367744Phase 2Results posted
- Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic SyndromeCompletedNCT00362440Phase 2Results posted
- Effects of a Uridine Supplement on HIV Infected Adults With LipoatrophyCompletedNCT00307164Phase 2/3Results posted
- Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or DyslipidemiaCompletedNCT00246376Not applicableResults posted
- Randomized, Placebo-Controlled Study of Leptin for the Treatment of HIV Lipodystrophy and Metabolic SyndromeCompletedNCT00140244Phase 2Results posted
- Study of Reyataz in HIV-infected Patients With Lipodystrophy SyndromeCompletedNCT00135356Phase 4Results posted
- Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin ResistanceCompletedNCT00130286Phase 1/2Results posted
- Observational Study of Fat Loss in HIV Infected Adults Taking Nucleoside Reverse Transcriptase Inhibitors (NRTIs)CompletedNCT00119405Results posted
- Effectiveness of Nucleoside Supplementation or Switch to Tenofovir in Reversing Fat Loss in HIV Infected AdultsCompletedNCT00119379Phase 2Results posted
- Physiologic Growth Hormone Effects in HIV LipodystrophyCompletedNCT00100698Not applicableResults posted
- Treatment of Abnormal Adipose Tissue Accumulation in Human Immunodeficiency Virus (HIV) PatientsCompletedNCT00082628Phase 3Results posted
- Leptin to Treat LipodystrophyCompletedNCT00025883Phase 2Results posted
- Safety and Efficacy of Deoxycholate Treatment of Small Fatty Deformities ( SFD)CompletedNCT07880301Phase 4
- Study of the Subdermal Implant "Algeness"CompletedNCT07618468Not applicable
- Study of the Subdermal Implant "Ultracol"CompletedNCT07617350Not applicable
- The Benefits of the Measureof Epicardial Adipose Tissue During Coronary Calcium Assessment of the Refine Cardiovascular Risk Assessment at Reunion Island.CompletedNCT07090629
- Impact of Lipodystrophy on the Inflammatory State of Non-diabetic Dunnigan Reunion Island SubjectsCompletedNCT06107439Not applicable
- Performance and Safety of the Lipo-transfer Cannulas in Patients Underlying Lipofilling TreatmentCompletedNCT06089759
- Carotid Doppler Peak Velocity Variation in Liposuction Fluid ManagementCompletedNCT05930106Not applicable
- Assess the Possibility of Diagnosing Diabetes and Rediabetes Following Oral Induced Hyperglycemia in Patients With Dunnigan's Partial Familial Lipodystrophy by Replacing 75 g of Glucose With a Standardized Carbohydrate Breakfast and Continuous Interstitial Monitoring Glucose)CompletedNCT05789251Not applicable
- Evaluation of HA Dermal Fillers in the Treatment of Pathological Facial LipoatrophyCompletedNCT05776836Not applicable
- Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane InjectionsStatus unknownNCT05608239Not applicable
- Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's LipodystrophyCompletedNCT05424913Not applicable
- Intraoperative Fluid Management of Liposuction , Cardiometry Versus Rohrich FormulaCompletedNCT05402982Not applicable
- The Visceral Adiposity Measurement and Observation StudyCompletedNCT05383456
- Evaluating Performance and Safety of the Medical Device Jalucomplex in the Treatment of Facial and Neck Tissue DefectsCompletedNCT05239351Not applicable
- Evaluating the Performance and Safety of the Medical Device Janesse in the Treatment of Facial Dermal Tissue DefectsCompletedNCT05239156Not applicable
- Evaluating the Performance and Safety of the Medical Device Auralya® in the Treatment of Facial Dermal Tissue DefectsStatus unknownNCT05239130Not applicable
- Evaluating the Performance and Safety of the Medical Device Plenhyage® in the Treatment of Dermal Tissue DefectsStatus unknownNCT05239117Not applicable
- A Study to Evaluate the Safety and Efficacy of Revanesse Shape + With Lidocaine Versus Juvederm Voluma With Lidocaine for the Correction of Age-Related Midface Volume Deficit / Lipoatrophy at 6 and 12 Months Post-treatmentCompletedNCT04927052Not applicable
- Changes in Weight, Body Composition and Cardiac Risk After Discontinuing Abacavir Treatment in HIV-infected IndividualsCompletedNCT04904406Phase 4
- Changes in Weight, Body Composition and Metabolic Parameters After Discontinuing Dolutegravir or Tenofovir DisproxilStatus unknownNCT04903847Phase 4
- Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTIStatus unknownNCT04887675Not applicable
- Effect of Berberine on Metabolic Syndrome, Efficacy and Safety in Combination With Antiretroviral Therapy in PLWH.Status unknownNCT04860063Phase 3
- Hemoglobin Level, Coagulopathy Profile and Electrolyte BalanceCompletedNCT04656054
- Insulin Regulated Amino Peptidase in Patients With Familial Lipodystrophy of DUNNIGANCompletedNCT04578379
- Contribution of Dolutegravir to Obesity and Cardiovascular DiseaseCompletedNCT04340388Phase 4
- Lipodystrophy and Fat Metabolism During ExerciseWithdrawnNCT04056000Not applicable
- Shockwave Therapy (SWT)CompletedNCT03986983Not applicable
- Growth Hormone Dynamics and Cardiac Steatosis in HIVCompletedNCT03826160
- Novel Mediators of the Lipodystrophy and Metabolic Consequences of Cushing's DiseaseCompletedNCT03817840
- Quality of Life, Sleep, and Biomarkers in People With HIV/AIDSCompletedNCT03445351Not applicable
- Different Surgical Modalities for Thigh Lipodystrophy Including Liposuction,Thigh Lift and Liposuction Assisted Thigh LiftStatus unknownNCT03283475Not applicable
- Shock Waves for Treatment of Gynoid Lipodystrophy and Localized FatCompletedNCT03275259Not applicable
- Setmelanotide in a Single Patient With Partial LipodystrophyCompletedNCT03262610Phase 2
- Motorized Mechanical Massage Associated With Cosmetics in Improving Body Contour and Appearance of Gynoid LipodystrophyStatus unknownNCT03199781Not applicable
- Detraining in People Living With HIV/AIDSCompletedNCT03075332Not applicable
- The Cleveland Cardiometabolic CohortCompletedNCT03059121
- Safety and Performance of Princess® VOLUME for the Treatment of Facial Lipoatrophy, Asymmetry or ScarsCompletedNCT03050749Not applicable
- Safety and Performance of Princess® FILLER for the Treatment of Facial Lipoatrophy, Asymmetry or ScarsCompletedNCT03050723Not applicable
- Immune Response to Pneumococcal Vaccination in Aging HIV Positive AdultsCompletedNCT03039491Early Phase 1
- Beneficial Effect of Insulin Glulisine by Lipoatrophy and Type 1 Diabetes (LAS)CompletedNCT02914886Phase 4
- Familial Partial Lipodystrophy StudyCompletedNCT02858830Not applicable
- Effects of TENS in Pain During Application of Carboxytherapy in Patients With Gynoid LipodystrophyCompletedNCT02743403Not applicable
- Phase 1 Study to Assess the Safety and Tolerability of TAT4 Gel in Healthy VolunteersCompletedNCT02647853Phase 1
- Prevalence of Lipodystrophy Syndrome and Its Role as Cause of Metabolic DisturbancesCompletedNCT02614027
- Lipodystrophy Connect Patient RegistryCompletedNCT02577952
- Energy Expenditure of People Living With HIV/AIDSCompletedNCT02530827
- Role of Mesenchymal Stem Cells in Fat GraftingStatus unknownNCT02494752Not applicable